Answers are grounded in this paper and cite their sources.
From a structure-activity relationship perspective, the new indolocarbazoles 11 and 12 have been synthesized and evaluated biologically as novel Chk1 inhibitors. Compounds 11 and 12 were synthesized in high yield from indole via bisindolylmaleimides 18 and 24.
No takes yet. Share an insight, caveat, or question.
Roy et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: